Case Reports in Medicine / 2014 / Article / Tab 1

Case Report

Fecal Transplantation Treatment of Antibiotic-Induced, Noninfectious Colitis and Long-Term Microbiota Follow-Up

Table 1

Mucosal bacteria with >2-fold change in relative abundance after FMT and constituting >0.01% of the microbiota.

Phylum/clusterIncreased bacterial groups
in colonic
Fold-change
B0 to B1
Increased in feces
F14 m and F2 w–7 

ActinobacteriaBifidobacterium spp.2.2Yes

BacteroidetesPrevotella melaninogenica et rel. 5.6No
Prevotella oralis et rel. 5.7No

Firmicutes/Clostridium cl. IVClostridium leptum et rel. 2.5Yes
Oscillospira guillermondii et rel. 4.8Yes
Sporobacter termitidis et rel. 2.7Yes
Anaerotruncus colihominis et rel. 3.4Yes
Ruminococcus callidus et rel. 4.1Yes
Ruminococcus lactaris et rel. 15.4No
Ruminococcus bromii et rel. 12.0Yes
Subdoligranulum variabile et rel. 7.9No

Firmicutes/Clostridium cl. IXDialister spp.3.6Yes

Firmicutes/Clostridium cl. XIVaLachnospira pectinoschiza et rel. 2.3Yes
Ruminococcus lactaris et rel. 15.4No
Butyrivibrio crossotus et rel. 2.5No
Clostridium colinum et rel. 3.3Yes

Uncult. ClostridialesUncult. ClostridialesI10.2Yes

ProteobacteriaOxalobacter formigenes 3.5Yes

Phylum/clusterDecreased bacterial groups
in colonic
Fold-change
B0 to B1
Decreased in feces
F14 m and F2 w–7 

BacteroidetesAlistipes et rel. 2.0No
Bacteroides stercoris et rel. 2.4No
Bacteroides vulgatus et rel. 9.6Yes
Bacteroides fragilis et rel. 2.1Yes
Bacteroides ovatus et rel. 3.4Yes
Bacteroides intestinalis et rel. 3.4No
Bacteroides plebeius et rel. 2.5No
Prevotella tannerae et rel. 6.2Yes
Tannerella et rel. 2.4No
Parabacteroides distasonis et rel. 4.0No
Uncult. Bacteroidetes5.9No

Firmicutes/Clostridium cl. IClostridia5.8No

Firmicutes/Clostridium cl. XIVaCoprococcus eutactus et rel. 2.4No
Dorea formicigenerans et rel. 4.0No
Eubacterium rectale et rel. 2.0No
Ruminococcus gnavus et rel. 7.0No
Ruminococcus obeum et rel. 4.4No
Clostridium nexile et rel. 5.3No
Outgr. Clostridium cl. XIVa6.2No

Firmicutes/Clostridium cl. IXVeillonella spp.2.7No
Megasphaera elsdenii et rel. 3.4No

Firmicutes/Clostridium cl. XIClostridium difficile et rel. 23.1No

Firmicutes/Clostridium cl. XVIBulleidia moorei et rel. 2.1No
Eubacterium cylindroides et rel. 2.2No

Firmicutes/Clostridium cl. XVIIIClostridium ramosum et rel. 8.1Yes

Firmicutes/BacilliStreptococcus bovis et rel. 2.3No
Streptococcus intermedius et rel. 2.3No
Streptococcus mitis et rel. 2.1No

ProteobacteriaSutterella wadsworthia et rel. 2.7No
Escherichia coli et rel. 3.7No
Klebsiella pneumonia et rel. 2.2No

Higher abundance also in the donor’s feces as compared to the patient’s pre-FMT feces; 2lower abundance also in the donor’s feces as compared to the patient’s pre-FMT feces, with the exception of C. eutactus et rel., E. rectale et rel., and S. bovis et rel.; 3increased/decreased abundance in 14 mo and in 2 w to 7 mo (average) post-FMT samples as compared to the pre-FMT fecal sample; Uncult.: uncultured; cl.: cluster; Outgr.: outgrouping.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.